首页|急性白血病合并血流感染病原菌及耐药性和Keap1、Nrf2、PD-1、PD-L1 mRNA对其预后的诊断价值

急性白血病合并血流感染病原菌及耐药性和Keap1、Nrf2、PD-1、PD-L1 mRNA对其预后的诊断价值

扫码查看
目的 分析急性白血病(AL)合并血流感染病原菌分布、耐药性及患者Kelch样环氧氯丙烷相关蛋白-1(Keap1)、核因子E2-相关因子2(Nrf2)、细胞程序性死亡受体-1(PD-1)、细胞程序性死亡配体-1(PD-L1)信使核糖核酸(mRNA)对其预后的诊断价值。方法 选取2019年1月—2023年7月山东大学齐鲁医院收治的198例AL合并血流感染患者为研究对象,统计其感染病原菌分布情况及主要感染病原菌耐药性,根据患者治疗30 d后预后情况将其分为死亡组(29例)和生存组(169例),统计两组临床特征及Keap1、Nrf2、PD-1、PD-L1 mRNA水平,采用受试者工作特征(ROC)曲线分析Keap1、Nrf2、PD-1、PD-L1 mRNA对AL合并血流感染患者预后的诊断价值。结果 AL合并血流感染患者检出革兰阴性菌占比56。59%,革兰阳性菌占比39。51%,真菌占比3。90%;大肠埃希菌对美罗培南、亚胺培南、阿米卡星、头孢他啶的耐药性均较低;表皮葡萄球菌对左氧氟沙星的耐药率为14。29%,对红霉素的耐药率为17。86%;肺炎链球菌对红霉素的耐药率为55。00%;死亡组单个淋巴核细胞Keap1、Nrf2、PD-L1 mRNA水平低于生存组(P<0。05),单个淋巴核细胞PD-1 mRNA水平高于生存组(P<0。05);Keap1、Nrf2、PD-1、PD-L1 mRNA联合预测AL合并血流感染患者预后的曲线下面积(AUC)值及敏感度均高于四者单独检测(P<0。05)。结论 AL患者革兰阴性菌血流感染的首选药物为美罗培南、亚胺培南、阿米卡星,革兰阳性菌感染则可优先采用环丙沙星、万古霉素、苯唑西林、庆大霉素、头孢唑林,Keap1、Nrf2、PD-1、PD-L1 mRNA联合检测可有效提高对AL合并血流感染患者预后的诊断价值。
Pathogens,drug resistance and value of Keap1,Nrf2,PD-1,and PD-L1 mRNA in diagnosis of prognosis of acute leukemia patients with bloodstream infection
OBJECTIVE To analyze the distribution and drug resistance of pathogens in acute leukemia(AL)com-plicated with bloodstream infection,and to investigate the diagnostic value of Kelch-like epichlorohydrin-related protein-1(Keap1),nuclear factor E2-related factor-2(Nrf2),programmed cell death receptor-1(PD-1)and pro-grammed cell death ligand-1(PD-L1)messenger RNA(mRNA)in prognosis.METHODS From Jan 2019 to Jul 2023,198 patients with AL complicated with bloodstream infection in Qilu Hospital of Shandong University were enrolled in the study.The distribution of pathogens and the main drug resistance of the pathogens were analyzed.According to the prognosis of the patients 30 days after treatment,they were divided into the death group(29 ca-ses)and survival group(169 cases).The clinical characteristics and Keap1,Nrf2,PD-1,and PD-L1 mRNA levels of the two groups were statistically analyzed.The diagnostic value of Keap1,Nrf2,PD-1,and PD-L1 mRNA for the prognosis of AL complicated with bloodstream infection was analyzed by receiver operating characteristic(ROC)curve analysis.RESULTS Gram-negative bacteria infection accounted for 56.59%,gram-positive bacteria infection accounted for 39.51%,and fungal infection accounted for 3.90%in AL patients complicated with blood-stream infection.The drug resistance of Escherichia coli to meropenem,imipenem,amikacin and ceftazidime was low.The drug resistance rate of Staphylococcus epidermidis to levofloxacin was 14.29%,and to erythromycin was 17.86%.The drug resistance rate of Streptococcus pneumoniae to erythromycin was 55.00%.The mRNA levels of Keap1,Nrf2,and PD-L1 in PMBC of the death group were lower than those in the survival group(P<0.05),while the mRNA levels of PD-1 were higher than those in PBMC of the survival group(P<0.05).The ar-ea under the curve(AUC)value and sensitivity of Keap1,Nrf2,PD-1,and PD-L1 mRNA combined detection in prediction of prognosis in patients with AL complicated by bloodstream infection were higher than those of individ-ual detecttion(P<0.05).CONCLUSION Meropenem,imipenem,and amikacin could be used as the preferred drugs for clinical treatment of gram-negative bacterial bloodstream infections in AL patients,while ciprofloxacin and vancomycin oxacillin,gentamicin and cefazolin could be given priority when the infection related to gram-posi-tive bacteria.The combined detection of Keap1,Nrf2,PD-1,and PD-L1 mRNA could effectively improve the di-agnostic value in the prognosis in patients with AL complicated with bloodstream infection.

Acute leukemiaBloodstream infectionPathogenDrug resistanceKelch-like epichlorohydrin related protein-1Nuclear factor E2-related factor 2Programmed cell death receptor-1Programmed cell death ligand-1Messenger RNAPrognosisDiagnostic value

李旻雪、董俊霞、张玉芬、曹乃月

展开 >

山东大学齐鲁医院(青岛)血液科,山东青岛 266000

青岛市市立医院保健门诊,山东青岛 266071

急性白血病 血流感染 病原菌 耐药性 Kelch样环氧氯丙烷相关蛋白-1 核因子E2-相关因子2 细胞程序性死亡受体-1 细胞程序性死亡配体-1 信使核糖核酸 预后 诊断价值

山东省自然科学基金青年基金

ZR2021QH326

2024

中华医院感染学杂志
中华预防医学会 中国人民解放军总医院

中华医院感染学杂志

CSTPCD北大核心
影响因子:1.885
ISSN:1005-4529
年,卷(期):2024.34(15)